Skip to main content
    O

    Oruka Therapeutics, Inc. (ORKA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $96.32
    -2.92 (-2.94%)

    Market Cap: $6.73B

    Last updated: Nov 17, 2026 at 4:33 PM ET

    Oruka Therapeutics, Inc. (ORKA) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Oruka Therapeutics (ORKA) has a latest price of $96.32 on Nov 17, 2026, 16.6% below its 52-week high of $115.52. Its price rose 255.7% over the past 12 months. The month-end price fell 79.6% over the 10 years through Oct 2026, a compound annual decline of 14.7%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $615.35 in Dec 2016 and its lowest $10.15 in Feb 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart ORKA with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ORKA.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 12.2%, and over 6 months it rose 67.5%. The month-end price rose 350.8% over the 3 years through Oct 2026, a compound annual rate of 65.2%.

    PeriodChange
    1 month+29.3%
    3 months-12.2%
    6 months+67.5%
    12 months+255.7%
    12 months, with dividends+255.7%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+350.8%+65.2%
    5 years+194.5%+24.1%
    10 years-79.6%-14.7%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 56.3%, and its weakest was 2018, when it fell 75.3%.

    YearCloseChange
    2026 through Oct 2026$96.87+219.6%
    2025$30.31+56.3%
    2024$19.39-5.0%
    2023$20.41-28.3%
    2022$28.45+10.2%
    2021$25.81-46.4%
    2020$48.14-29.8%
    2019$68.55-4.8%
    2018$72.01-75.3%
    2017$291.48-52.6%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 7.2% above its 50-day average of $89.85 and 31.4% above its 200-day average of $73.29.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$96.32
    52-week high$115.52-16.6%
    52-week low$25.23+281.8%
    50-day average$89.85+7.2%
    200-day average$73.29+31.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 77.8%.

    MeasureValue
    1-year beta1.48
    Largest fall, 1 year-36.4%
    Largest fall, 3 years-77.8%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About ORKA

    What is ORKA's 1-year price change?

    Oruka Therapeutics's price rose 255.7% over the past 12 months. With dividends included, the 12-month total return was 255.7%.

    What is ORKA's 5-year price change?

    Oruka Therapeutics's month-end price rose 194.5% over the 5 years through Oct 2026, a compound annual rate of 24.1%. These figures leave out dividends.

    What is ORKA's 52-week high and low?

    Oruka Therapeutics's 52-week high is $115.52 and its 52-week low is $25.23. Its latest price of $96.32 on Nov 17, 2026 is 16.6% below the high.

    What is ORKA's beta?

    Oruka Therapeutics's 1-year beta against the S&P 500 is 1.48, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 36.4%.

    Is the ORKA chart free?

    Yes. Advanced Charting for ORKA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.